Ionis Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.60 billion, with shareholders equity totaling $393.64 million.
The company employs approximately 817 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Ionis Pharmaceuticals Inc. reported $960.09 million in revenue, generating net income of $-546.54 million.
Key financial metrics include a P/E ratio of -8.42, a price-to-book (P/B) ratio of 11.70, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker IONS.